Fig. 3
From: Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma
Kaplan-Meier analyses for overall survival and disease free survival of patients in UISS (non-metastatic) subgroups. Overall survival for patients in the UISS (non-metastatic) low risk group (a) and intermediate/high risk group (b) according to ST3GAL-1 expression; disease free survival for patients in the UISS (non-metastatic) low risk group (c) and intermediate/high risk group (d) according to ST3GAL-1 expression; UISS: University of California Los Angeles Integrated Staging System; p -value was calculated by Log rank test, <0.05 was regarded as statistically significant